Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold with apoptotic activity

Cyclin-dependent kinase inhibition is considered a promising target for cancer treatment for its crucial role in cell cycle regulation. Pyrazolo pyrimidine derivatives were well established for their antitumor activity via CDK2 inhibition. In this research, new series of pyrazolopyrimidine derivativ...

Full description

Saved in:

Bibliographic Details
Main Authors:	Asmaa A. Mandour, Ibrahim F. Nassar, Mohammed T. Abdel Aal, Mahmoud A. E. Shahin, Wael A. El-Sayed, Maghawry Hegazy, Amr Mohamed Yehia, Ahmed Ismail, Mohamed Hagras, Eslam B. Elkaeed, Hanan M. Refaat, Nasser S. M. Ismail
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-12-01
Series:	Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:	Pyrazolopyrimidine CDK2 apoptosis cytotoxicity ADMET
Online Access:	https://www.tandfonline.com/doi/10.1080/14756366.2022.2086866
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold with apoptotic activity

Similar Items